Space Industry and Business News
SPACE MEDICINE
Accelerated muscle loss model in microgravity could aid Sarcopenia treatment research
illustration only
Accelerated muscle loss model in microgravity could aid Sarcopenia treatment research
by Clarence Oxford
Los Angeles CA (SPX) Oct 18, 2024

Sarcopenia, a condition that affects over 50 million people globally, results in the loss of muscle mass, strength, and function with age, heightening the risk of falls and fractures. Currently, exercise is the only recognized treatment. However, research sponsored by the International Space Station (ISS) National Lab and conducted by University of Florida scientists has developed a microgravity-based model of age-related muscle loss using tissue chips. This model offers new opportunities to test treatments and study the condition in ways that are impossible on Earth.

This study is highlighted in the latest issue of 'Upward', the official magazine of the ISS National Lab. Principal investigator Siobhan Malany, an associate professor at the University of Florida's College of Pharmacy, noted, "Through insight we gather from microgravity, we can understand not just the end result of [sarcopenia], but really look at the progressive change in young and old cells to see what happens as cells age."

Studying muscle degeneration on Earth is challenging because it occurs over many years. In contrast, microgravity accelerates muscle loss, allowing faster research results. In a series of studies funded by the National Institutes of Health (NIH), the research team developed a muscle tissue chip system to test whether muscle loss in microgravity resembles age-related muscle degeneration. The chips used muscle cells from both young and older adults, with some chips receiving electrical stimulation to trigger muscle contraction.

The results revealed that several genes linked to muscle aging were upregulated in the tissue chips with cells from young adults, confirming the effectiveness of this space-based system in replicating age-related muscle loss. This innovation offers a critical new tool for studying sarcopenia and testing potential therapies.

Related Links
International Space Station U.S. National Laboratory
Space Medicine Technology and Systems

Subscribe Free To Our Daily Newsletters
Tweet

RELATED CONTENT
The following news reports may link to other Space Media Network websites.
SPACE MEDICINE
Accelerated Muscle Loss Model in Space May Lead to Sarcopenia Treatments
Los Angeles CA (SPX) Oct 17, 2024
More than 50 million people worldwide suffer from sarcopenia, an age-related condition that causes muscle loss, weakened strength, and reduced functionality, increasing the likelihood of falls and fractures, according to the World Health Organization. Currently, exercise is the only known treatment. However, researchers at the University of Florida, through a study sponsored by the ISS National Lab, have successfully modeled age-related muscle deterioration using tissue chips in the microgravity environ ... read more

SPACE MEDICINE
OKI to produce satellite units for Astroscale

SatixFy inks $9M software deal with MDA Space for satellite payload technology

Space agencies tracking debris from Boeing-built satellite's explosion in orbit

NASA testing deployable solar array on Pathfinder Mission

SPACE MEDICINE
SDA Selects AST SpaceMobile and Muon Space for HALO Program to Enhance Proliferated LEO Capabilities

Eutelsat Group launches 20 OneWeb satellites to expand LEO Network

Intelsat and US Army Complete pilot program for Managed Satellite Communication Services

ViaSat-3 F1 Now Providing Services to Government Customers

SPACE MEDICINE
SPACE MEDICINE
GMV GSharp leads globally in precise GNSS corrections

LEO satellites hold the key to resilient, interference-free navigation

China launches two more satellites for Beidou navigation system

SpaceX launches European Galileo satellites to medium Earth orbit

SPACE MEDICINE
US approves $7.3 bn sale of F-16 upgrades for Poland

Hydrogen aviation has to be done properly or not at all

NASA Pilots Add Perspective to Research

US regulator finalizes air taxi rules

SPACE MEDICINE
Taiwan's TSMC stops shipments to client after chips sent to Huawei

How to build a quantum computer that's actually useful

SKhynix posts record quarterly profit on strong AI demand

Taiwan's TSMC posts sharp rise in third quarter net profit

SPACE MEDICINE
NASA's C-130 aircraft en route to india in support of NISAR mission

Planet Lab launches analysis-ready PlanetScope for time-series and machine learning applications

China deploys new Yaogan-43 remote-sensing satellite group

Future of Copernicus Sentinel Expansion missions secured

SPACE MEDICINE
EU delays on dangerous chemicals threaten health, environment

East DR Congo grapples with Chinese gold mining firms

NGO urges Albania to 'transparently' probe suspected toxic waste

Chair of global plastics talks pledges deal next month

Subscribe Free To Our Daily Newsletters




The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.